Market Cap (In CNY)
3.98 Billion
Revenue (In CNY)
413.65 Million
Net Income (In CNY)
190.95 Million
Avg. Volume
2.53 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 17.65-29.27
- PE
- -
- EPS
- -
- Beta Value
- 0.321
- ISIN
- CNE100002NZ1
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Kan Song
- Employee Count
- -
- Website
- https://www.zhbio.com
- Ipo Date
- 2017-05-16
- Details
- Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and marketing of regenerative medical materials in China. It offers bone repair material, a partially deproteinised bone prepared from cancellous bones of calves after a series of treatment, such as decellularization and degreasing; oral cavity repair membrane line of products, which are used to treat defects of shallow oral cavity's soft tissue; and bio-membrane line of products that are used in neurosurgery to repair cerebral dura mater defect under the Heal-All brand name. The company also provides skin repair membrane line of products to repair wounds in dermal layer under the Heal-Full brand name. Yantai Zhenghai Biotechnology Co., Ltd. was founded in 2003 and is based in Yantai, China.
More Stocks
-
WELLWelltower Inc.
WELL
-
HGTYHagerty, Inc.
HGTY
-
DPLSDarkPulse, Inc.
DPLS
-
011930Shinsung E&G Co., Ltd.
011930
-
LY0Lyft, Inc.
LY0
-
WBZB
-
0K19
-
SURVF